Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali
JournalClinical Microbiology and Infection
MetadataShow full item record
AbstractObjectives: In Mali early detection and treatment of multidrug-resistant tuberculosis (MDR-TB) are still challenging due to the cost, time and/or complexity associated with regular tests. Microscopic Observation Drug Susceptibility (MODS) is a low-cost assay validated by WHO in 2010. It is a liquid-culture-based assay to detect the ‘cording’ characteristic of Mycobacterium tuberculosis complex and to assess susceptibility to both isoniazid and rifampicin defining multidrug-resistant tuberculosis (MDR-TB). In this study we aimed to evaluate the performance of MODS as diagnostic tool compared with a validated method—Mycobacteria Growth Indicator Tube/Antimicrobial Susceptibility Testing/Streptomycin, Isoniazid, Rifampicin and Ethambutol (MGIT/AST/SIRE). Methods and Results: Between January 2010 and October 2015 we included 98 patients with suspected TB in an observational cohort study. The sensitivity and specificity of MODS assay for detecting TB were respectively 94.12% and 85.71% compared with the reference MGIT/7H11 culture, with a Cohen κ coefficient of 0.78 (95% CI 0.517–1.043). The median time to culture positivity for MODS assay and MGIT (plus interquartile range, IQR) was respectively 8 days (IQR 5–11) and 6 days (IQR 5–6). In detecting patients with MDR-TB, the sensitivity and specificity of MODS assay were respectively 100% and 95.92%. The positive predictive value and negative predictive value were, respectively, 66.7% and 100%. The median turnaround times for obtaining MDR-TB results using MODS assay and MGIT/AST/SIRE was respectively 9 days and 35 days. Hence, the MODS assay rapidly identifies MDR-TB in Mali compared with the MGIT/AST/SIRE. Conclusion As an easy, simple, fast and affordable method, the MODS assay could significantly improve the management of TB. Copyright 2017 European Society of Clinical Microbiology and Infectious Diseases
Microscopic observation and drug susceptibility
Mycobacteria Growth Indicator Tube/Antimicrobial Susceptibility Testing/Sterptomycin, Isoniazid, Rifampicin and Ethambutol
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85013499550&doi=10.1016%2fj.cmi.2017.01.004&partnerID=40&md5=f4dcface26c48d9501c64fc7d5d2e1fb; http://hdl.handle.net/10713/9880
- Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
- Authors: Dang TM, Nguyen TN, Wolbers M, Vo SK, Hoang TT, Nguyen HD, To MH, Vuong MB, Nguyen TP, Tran VQ, Nguyen TB, Vo TH, Nguyen TN, Dai VH, Phan TH, Nguyen HD, Farrar J, Caws M
- Issue date: 2012 Mar 1
- Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
- Authors: Shah NS, Moodley P, Babaria P, Moodley S, Ramtahal M, Richardson J, Heysell S, Li X, Moll A, Friedland G, Sturm AW, Gandhi NR
- Issue date: 2011 May 15
- Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.
- Authors: Rasslan O, Hafez SF, Hashem M, Ahmed OI, Faramawy MA, Khater WS, Saleh DA, Mohamed MI, Khalifa MA, Shoukry FA, El-Moghazy EH
- Issue date: 2012 Jul
- Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
- Authors: Huang Z, Qin C, Du J, Luo Q, Wang Y, Zhang W, Zhang X, Xiong G, Chen J, Xu X, Li W, Li J
- Issue date: 2015 Feb
- Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.
- Authors: Makamure B, Mhaka J, Makumbirofa S, Mutetwa R, Mupfumi L, Mason P, Metcalfe JZ
- Issue date: 2013